Keywords: افزایش; Glucagon; GIP; GLP-1; Insulin releasing polypeptide (IRP); Immunoassay; Incretin;
مقالات ISI افزایش (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: افزایش; Glucagon; Diabetes; Obesity; Energy expenditure; Incretin; Oxyntomodulin;
Keywords: افزایش; cardiovascular; diabetic kidney disease; endothelin; heart failure; incretin; inflammation; mineralocorticoid; SGLT2 inhibition; uric acid;
Keywords: افزایش; GLP-1; GIP; Incretin; Diabetes; KÂ cells; LÂ cells;
Keywords: افزایش; Incretin; GLP-1; Exenatide; DPP-IV; Sitagliptin; Atherosclerosis; Endothelial cell function; Incretin therapy; Vascular inflammation; Cardiovascular diseases;
Keywords: افزایش; Late-stage functionalization; Lipidation; Peptides; Incretin; Glucagon;
Keywords: افزایش; AP; area postrema; DMV; dorsal motor nucleus of the vagus; DSG; dorsal swallowing group; DVC; dorsal vagal complex; L-DVC; lateral part of the DVC; M-DVC; medial part of the DVC; GLP-1; glucagon like peptide-1; NTS; nucleus tractus solitarius; cNTS; commi
Keywords: افزایش; Incretin; National Health Insurance; Population-based study; Propensity score; Taiwan;
Keywords: افزایش; Type 1 diabetes; DPP-4; GLP-1; Incretin;
Keywords: افزایش; Glucagon-like peptide-1; Glucose-dependent insulinotropic polypeptide; Incretin; Glucose; Older subjects;
Keywords: افزایش; Lipidated peptide; Incretin; GLP1; Oligomerization; Albumin binding; Surface plasmon resonance;
Keywords: افزایش; AUC; area under the curve; BMI; body mass index; CaSR; calcium sensing receptor; CV; coefficient of variation; DPP-IV; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1; GPCR; G-protein coupled receptor; HV; healthy volunteer; OGTT; oral glucose tol
Keywords: افزایش; Bariatric; Ghrelin; Gastrin; Cholecystokinin; Incretin; Oxyntomodulin;
Keywords: افزایش; Feline; Diabetes; Insulin; Glucagon; Incretin;
Keywords: افزایش; Feline; Exenatide; Incretin; Diabetes; Insulin; Glucagon;
Keywords: افزایش; Neonatal weight gain; Maternal high-fat diet; Insulin; Incretin; GhrelinPND, postnatal day; GLP-1, glucagon-like peptide 1; GIP, glucose-dependent insulinotropic polypeptide; GOAT, ghrelin-O-acyltransferase; Pdx-1, pancreas duodenum homeobox-1; Ghrl, ghre
Keywords: افزایش; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; DPP-4; dipeptidyl peptidase-4; BMI; body mass index; CNS; central nervous system; EMA; European Medicines Agency; FDA; US Food and Drug Administration; (Pro3)GIP; proline-3
Keywords: افزایش; Feline; Sitagliptin; Incretin; Glucagon-like peptide 1; Glucose-dependent insulinotropic polypeptide
Keywords: افزایش; Cardiovascular disease; Dipeptidyl peptidase-4 inhibitor; Dyslipidemia; Incretin; Statin;
Keywords: افزایش; gastric bypass; incretin; metabolic surgery; type 2 diabetes mellitus
Keywords: افزایش; Key Indexing Terms; Hypoglycemia; Incretin; Insulin; Type 2 diabetes mellitus
Keywords: افزایش; ABA; abscisic acid; PA; phaseic acid; DPA; dihydrophaseic acid; 7-OH-ABA; 7-hydroxy-abscisic acid; ABA-GE; abscisic acid glucose ester; trans-ABA; trans abscisic acid; Neo-PA; neo-phaseic acid; HbA1c; higher glycated haemoglobin 1c; CVD; cardiovascular di
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Keywords: افزایش; DPP-4; dipeptidyl peptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; GRP; gastrin-releasing peptide; NEP; neutral endopeptidase; OXM; oxyntomodulin; PACAP; pituitary adenylate cyclase-activating polypeptide; PY
The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoEâ/â mice by blocking monocyte/macrophage activation
Keywords: افزایش; Incretin; GIP; Atherosclerosis; Plaque stability; PAD; Macrophages;
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
Keywords: افزایش; Incretin; DPP4 inhibitors; long-term care; nursing home; skilled nursing facilities; glargine; linagliptin; basal insulin; hospital hyperglycemia; older adults; diabetes;
Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson's disease mouse model
Keywords: افزایش; Incretin; Insulin; Autophagy; Inflammation; Dopamine; Growth factor;
Characteristics of repaglinide effects on insulin secretion
Keywords: افزایش; Insulin secretion; β-cell; Glinide; Sulfonylurea; Incretin;
Exenatide Prevents Morphological and Structural Changes of Mitochondria Following Ischaemia-Reperfusion Injury
Keywords: افزایش; Ischaemia-reperfusion injury; Mitochondria; Atomic force microscopy; Incretin;
Incretin effect of Urena lobata leaves extract on structure and function of rats islet β-cells
Keywords: افزایش; Islet β-cells; GLP-1; Incretin; Insulin; U. lobata;
Research reportA novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model
Keywords: افزایش; Alzheimer's disease; Incretin; Insulin signaling; Apoptosis; Inflammation; Tau phosphorylation; Type 2 diabetes mellitus;
Attenuated diuresis and natriuresis in response to glucagon-like peptide-1 in hypertensive rats are associated with lower expression of the glucagon-like peptide-1 receptor in the renal vasculature
Keywords: افزایش; Hypertension; Incretin; Renal function; Renal vascular resistance; Renal artery;
D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
Keywords: افزایش; Neurodegeneration; Insulin; Brain; Incretin; Growth factor; Dopamine;
A novel GLP-1/GIP dual receptor agonist protects from 6-OHDA lesion in a rat model of Parkinson's disease
Keywords: افزایش; Neurodegeneration; Brain; Insulin; Neuroprotection; Neuron; Incretin;
Anti-obesogenic and hypolipidemic effects of a glucagon-like peptide-1 receptor agonist derived from the saliva of the Gila monster
Keywords: افزایش; Obesity; Dyslipidemia; Incretin; Drug repurposing; Lizard toxin; AUC; area under the time-course curve of glycemia; DIO; obesity induced by high-calorie diet; DIO-E; obesity induced by high-calorie diet treated with exenatide; T2D; type 2 diabetes mellitu
Neonatal GLP1R activation limits adult adiposity by durably altering hypothalamic architecture
Keywords: افزایش; Obesity; Metabolism; Incretin; Beige fat; Hypothalamic architecture;
Gold nanoparticles as an efficient drug delivery system for GLP-1 peptides
Keywords: افزایش; GLP-1; Gold nanoparticles; Caco-2 cells; Solid-phase peptide synthesis; Incretin;
Endoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action
Keywords: افزایش; Obesity; Bariatric; Endoscopy; Metabolic; Diabetes; Endoscopic Sleeve Gastroplasty; ESG; POSE; Gastric Balloon; Orbera; Duo; Obalon; Aspire; EndoBarrier; IMAS; Magnetic; Ghrelin; GLP-1; PYY; EBT; EBMT; Incretin; BMI; body mass index; BPD; biliopancreatic
Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion
Keywords: افزایش; GLP-1; GIP; Incretin; Secretagogue; TGR5;
Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice
Keywords: افزایش; Adenylyl cyclase; cAMP; CB1; GLP-1; Incretin; Insulin secretionAC, Adenylyl cyclase; ACEA, arachidonoyl 2′-chloroethylamide; AEA, anandamide; 2-AG, 2-arachidonoylglycerol; EC, endocannabinoid; GIP, glucose-dependent insulinotropic peptide; GLP-1, glucagon
Safety and Efficacy of Incretin-Based Therapies in Patients With Type 2 Diabetes Mellitus and CKD: A Systematic Review and Meta-analysis
Keywords: افزایش; Type 2 diabetes mellitus (T2DM); chronic kidney disease (CKD); systematic review; epidemiology; meta-analysis; pharmacoepidemiology; antidiabetic therapies; safety; efficacy; incretin; dipeptidyl peptidase 4 inhibitor (DPP-4); glucagon-like peptide 1 (GLP
A novel dual GLP-1 and GIP receptor agonist is neuroprotective in the MPTP mouse model of Parkinson′s disease by increasing expression of BNDF
Keywords: افزایش; Insulin; Apoptosis; Incretin; Growth factor; AKT; Neuron
Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo
Keywords: افزایش; Gemigliptin (PubChem CID: 11953153); Vildagliptin (PubChem CID: 11077541); Sitagliptin (PubChem CID: 11591741); Dipeptidyl peptidase-4 inhibitor; Gemigliptin; Incretin; Type 2 diabetes mellitus;
Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans
Keywords: افزایش; Glucagon-like peptide-1; Incretin; Brain; fMRI; Orbitofrontal cortex; Brain insulin resistance
Wholegrain barley β-glucan fermentation does not improve glucose tolerance in rats fed a high-fat diet
Keywords: افزایش; β-Glucan; Barley; Incretin; Satiety; Glycemic index; SCFA; Wholegrain; GIP; gastric inhibitory peptide; GLP-1; glucagon-like peptide-1; HBG; high β-glucan; LBG; low β-glucan; Bgl; β-glucan less; PYY; polypeptide-YY; SCFA; short-chain fatty acid; T2D;
Simultaneous quantification of intracellular and secreted active and inactive glucagon-like peptide-1 from cultured cells
Keywords: افزایش; Glucagon-like peptide-1; Incretin; Selected reaction monitoring; Absolute quantification; Secretopeptidome; LC-MS/MS;
Research reportNeuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model
Keywords: افزایش; Growth factors; Incretin; Neuroinflammation; Apoptosis; Neuroprotection; Insulin;
Neuroprotective effects of an oxyntomodulin analogue in the MPTP mouse model of Parkinson's disease
Keywords: افزایش; Growth factor; Incretin; GLP-1; Glucagon; Insulin; Neurodegeneration; Mice;
Effects of incretin agonists on endothelial nitric oxide synthase expression and nitric oxide synthesis in human coronary artery endothelial cells exposed to TNFα and glycated albumin
Keywords: افزایش; Coronary artery endothelium; Incretin; Nitric oxide synthase; TNFα; Glycated albumin
Dpp4 inhibition as a therapeutic strategy in cardiometabolic disease: Incretin-dependent and -independent function
Keywords: افزایش; DPP4; Incretin; GLP-1; Cardiometabolic disease; Diabetes
Ghrelin regulates GLP-1 production through mTOR signaling in L cells
Keywords: افزایش; Enteroendocrine L cells; Ghrelin; GHSR1a; GLP-1; Incretin; mTORC1D-Lys-3-GHRP-6, D-Lys-3-GH-releasing peptide-6; GCG, Proglucagon; GLP-1, Glucagon-like peptide-1; mTOR, mechanistic target of rapamycin; Raptor, regulatory-associated protein of mTOR; S6, ri